Evidence map›Paper›PMID 34850835›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Complexity of Genomic Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolates in Colombia Urges the Reinforcement of Whole Genome Sequencing-Based Surveillance Programs.

Sandra Yamile Saavedra, Johan Fabian Bernal, Efraín Montilla-Escudero, Stefany Alejandra Arévalo, Diego Andrés Prada, María Fernanda Valencia, Jaime Moreno, Andrea Melissa Hidalgo, Ángela Sofía García-Vega, Monica Abrudan and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Plasmid-mediated carbapenem resistance: global dissemination patterns and replicon-gene associations.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  5. New Insights inAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Clonal Dissemination of Pandrug-ResistantInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Emerging carbapenem-resistantMicrobiology spectrum · 2025
    Article
  10. Genomic Characterization of Intestinal ColonizingInfection and drug resistance · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Plasmid genomic epidemiology ofAntimicrobial agents and chemotherapy · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Molecular Epidemiology of Carbapenem ResistantInfection and drug resistance · 2023
    Article
  19. Review
  20. Genomics ofMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Sandra Yamile SaavedraGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Johan Fabian BernalColombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS), CI Tibaitatá, Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), Tibaitatá - Mosquera, Cundinamarca, Colombia.
Efraín Montilla-EscuderoGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Stefany Alejandra ArévaloColombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS), CI Tibaitatá, Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), Tibaitatá - Mosquera, Cundinamarca, Colombia.
Diego Andrés PradaGrupo de Microbiología, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
María Fernanda ValenciaColombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS), CI Tibaitatá, Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), Tibaitatá - Mosquera, Cundinamarca, Colombia.
Jaime MorenoGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Andrea Melissa HidalgoGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Ángela Sofía García-VegaColombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS), CI Tibaitatá, Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), Tibaitatá - Mosquera, Cundinamarca, Colombia.
Monica AbrudanCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Silvia ArgimónCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Mihir KekreCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Anthony UnderwoodCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
David M AanensenCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Carolina DuarteGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Pilar Donado-GodoyColombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS), CI Tibaitatá, Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), Tibaitatá - Mosquera, Cundinamarca, Colombia.
NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance
Instituto Nacional de Salud · COColombian Corporation for Agricultural Research - AGROSAVIA · COUniversity of Oxford · GB

Funding

National Institute for Health Research 136/111
6 · The paper itself

Abstract

backgroundCarbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging public health problem. This study explores the specifics of CRKP epidemiology in Colombia based on whole genome sequencing (WGS) of the National Reference Laboratory at Instituto Nacional de Salud (INS)'s 2013-2017 sample collection.

methodsA total of 425 CRKP isolates from 21 departments were analyzed by HiSeq-X10®Illumina high-throughput sequencing. Bioinformatic analysis was performed, primarily using the pipelines developed collaboratively by the National Institute for Health Research Global Health Research Unit (GHRU) on Genomic Surveillance of Antimicrobial Resistance (AMR), and AGROSAVIA.

resultsOf the 425 CRKP isolates, 91.5% were carbapenemase-producing strains. The data support a recent expansion and the endemicity of CRKP in Colombia with the circulation of 7 high-risk clones, the most frequent being CG258 (48.39% of isolates). We identified genes encoding carbapenemases blaKPC-3, blaKPC-2, blaNDM-1, blaNDM-9, blaVIM-2, blaVIM-4, and blaVIM-24, and various mobile genetic elements (MGE). The virulence of CRKP isolates was low, but colibactin (clb3) was present in 25.2% of isolates, and a hypervirulent CRKP clone (CG380) was reported for the first time in Colombia. ST258, ST512, and ST4851 were characterized by low levels of diversity in the core genome (ANI > 99.9%).

conclusionsThe study outlines complex CRKP epidemiology in Colombia. CG258 expanded clonally and carries specific carbapenemases in specific MGEs, while the other high-risk clones (CG147, CG307, and CG152) present a more diverse complement of carbapenemases. The specifics of the Colombian situation stress the importance of WGS-based surveillance to monitor evolutionary trends of sequence types (STs), MGE, and resistance and virulence genes.

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsColombiaGenomicsHumansMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsantimicrobial resistanceCarbapenemasesKlebsiella pneumoniaewhole genome sequence (WGS)

Identifiers

PMID34850835
PMCPMC8634422
OpenAlexW3215708732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.